39
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Characterization of two isoalleles and three mutations in both isoforms of purified recombinant human porphobilinogen deaminase

, , , &
Pages 93-106 | Received 08 Mar 2004, Accepted 18 Aug 2004, Published online: 08 Jul 2009

References

  • Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited diseases. 7th ed. New York: McGraw-Hill; 1995. pp 2103–60.
  • McColl KE, Moore MR, Thompson GG, Goldberg A. Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities. J Med Genet 1982;19:271–6.
  • Nissen H, Petersen NE, Mustajoki S. Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis. Hum Mutat 1997;9:122–30.
  • Grandchamp B. Acute intermittent porphyria. Semin Liver Dis 1998;18:17–24.
  • Mustajoki P, Kauppinen R, Lannfelt L, Lilius L, Koistinen J. Frequency of low erythrocyte porphobilinogen deaminase activity in Finland. J Intern Med 1992;231:389–95.
  • Puy H, Deybach JC, Lamoril J. Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. Am J Hum Genet 1997;60:1373–83.
  • Chretien S, Dubart A, Beaupain D. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci USA 1988;85:6–10.
  • Grandchamp B, de Verneuil H, Beaumont C, Chretien S, Walter 0, Nordmann Y. Tissue-specific expression of porphobilinogen deaminase. Two isoenzyrnes from a single gene. Eur J Biochem 1987;162: 105–10.
  • Raich N, Romeo PH, Dubart A, Beaupain D, Cohen-Solal M, Goossens M. Molecular cloning and complete primary sequence of human erythrocyte porphobilinogen deaminase. Nucleic Acids Res 1986;14:5955–68.
  • Yoo HW, Warner CA, Chen CH, Desnick RJ. Hydroxymethylbilane synthase: complete genomic sequence and amplifiable polymorphisms in the human gene. Genomics 1993;15:21–9.
  • Jordan PM, Woodcock SC. Mutagenesis of arginine residues in the catalytic cleft of Escherichia coli porphobilinogen deaminase that affects dipyrromethane cofactor assembly and tetrapyrrole chain initiation and elongation. Biochem J 1991;280:445–9.
  • Lander M, Pitt AR, Alefounder PR, Bardy D, Abell C, Battersby AR. Studies on the mechanism of hydroxyrnethylbilane synthase concerning the role of arginine residues in substrate binding. Biochem J 1991;275:447–52.
  • Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–9.
  • Sambrook J, Fritsch EF, Maniatis T. Plasmid vectors. In: Sambrook J, Fritsch EF, Maniatis T, editors. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, USA: Cold Spring Harbor Laboratory Press; 1989. pp 1.25–8.
  • Brons-Poulsen J, Petersen NE, Horder M, Kristiansen K. An improved PCR-based method for site directed mutagenesis using megaprimers. Mol Cell Probes 1998;12:345–8.
  • Brons-Poulsen J, Nohr J, Larsen LK. Megaprimer method for polymerase chain reaction-mediated generation of specific mutations in DNA. Methods Mol Biol 2002;182:71–6.
  • Goloubinoff P, Gatenby AA, Lorimer GH. GroE heat-shock proteins promote assembly of foreign prokaryotic ribulose bisphosphate carboxylase oligomers in Escherichia coli. Nature 1989;37:4–7.
  • Nordmann Y, Puy H, Da SV. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France. J Intern Med 1997;242:213–7.
  • Desnick RJ, Ostasiewicz LT, Tishler PA, Mustajoki P. Acute intermittent porphyria: characterization of a novel mutation in the structural gene for porphobilinogen deaminase. Demonstration of noncatalytic enzyme intermediates stabilized by bound substrate. J Chin Invest 1985;76:865–74.
  • Kauppinen R, Peltonen L, Pihlaja H, Mustajoki P. GRIM-positive mutations of acute intermittent porphyria in Finland. Hum Mutat 1992;1:392–96.
  • Brownlie PD, Lambert R, Louie GV. The three-dimensional structures of mutants of porphobilinogen deaminase: toward an understanding of the structural basis of acute intermittent porphyria. Protein Sci 1994;3:1644–50.
  • Jensen TG, Bross P, Andresen BS. Comparison between medium-chain acyl-CoA dehydrogenase mutant proteins overexpressed in bacterial and mammalian cells. Hum Mutat 1995;6:226–31.
  • Guise AD, West SM, Chaudhuri JB. Protein folding in vivo and renaturation of recombinant proteins from inclusion bodies. Mol Biotechnol 1996;6:53–64.
  • Louie GV, Brownlie PD, Lambert R. The three-dimensional structure of Escherichia coli porphobilinogen deaminase at 1.76-A resolution. Proteins 1996;25: 48–78.
  • Lerman LS, Silverstein K. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol 1987;155:482–501.
  • McTigue MA, Bernstein SL, Williams DR, Tainer JA. Purification and crystallization of a schistosomal glutathione 5-transferase. Proteins 1995;22:55–7.
  • Delfau MH, Picat C, de Rooij FW. Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria. J Chin Invest 1990;86:1511–6.
  • Anderson PM, Desnick RJ. Purification and properties of uroporphyrinogen I synthase from human erythrocytes. Identification of stable enzyme-substrate intermediates. J Biol Chem 1980;255:1993–9.
  • Meissner P, Adams P, Kirsch R. Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria. J Chin Invest 1993;91:1436–44.
  • Sassa S, Zalar GL, Kappas A. Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes. J Chin Invest 1978;61:499–508.
  • Ong PM, Lanyon WG, Graham G. Acute intermittent porphyria: the in vitro expression of mutant hydroxymethylbilane synthase. Mol Cell Probes 1997;11:293–6.
  • Chen CH, Astrin KH, Lee G, Anderson KE, Desnick RJ. Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxyrnethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme. J Chin Invest 1994;94: 1927–37.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.